Immediate Impact

75 standout
Sub-graph 1 of 19

Citing Papers

Immune responses to human fungal pathogens and therapeutic prospects
2023 Standout
Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
2023 Standout
47 intermediate papers

Works of Gary Gartenberg being referenced

A phase 2, randomized, double‐blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low‐ or intermediate‐1–risk myelodysplastic syndrome
2014
Hospital-Acquired Mucormycosis (Rhizopus rhizopodiformis) of Skin and Subcutaneous Tissue
1978

Author Peers

Author Last Decade Papers Cites
Gary Gartenberg 50 33 141 118 11 269
Stacey Rose 13 17 69 94 14 221
Colleen Lowry 23 11 225 195 10 334
Wilhelm G. Struff 33 10 115 83 13 298
Raj Purgus 21 8 122 34 11 272
Stacey A. Henning 20 8 139 126 9 287
Anthony I. Sahyoun 9 11 92 101 12 321
R. Purgus 20 9 44 119 16 324
Kaplan Mh 11 9 62 70 21 296
Olga Moser 22 26 55 74 19 226
Emma Paige 5 8 106 136 11 254

All Works

Loading papers...

Rankless by CCL
2026